Enrocure 10% Injectable Solution

COMPOSITION
Each ml contains 100 mg of enrofloxacin and 30 mg of n-butanol as an preservative.
 
INDICATIONS FOR USE
Cattle
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mannheimia haemolytica, haemolytica and Mycoplasma spp.
Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis in cattle
less than 2 years old.
 
Sheep
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of mastitis caused by enrofloxacin susceptible strains of Staphylococcus aureus and Escherichia coli.
 
Goats
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida and Mannheimia haemolytica. haemolytica.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of mastitis caused by enrofloxacin susceptible strains of Staphylococcus aureus
aureus and Escherichia coli.
 
ADMINISTRATION ROUTES AND AMOUNTS
Repeated injections should be made at different injection sites.
To ensure a correct dosage, body weight (bw) should be determined as accurately as
possible to avoid underdosing.
 
Cattle
5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 3–5 days.
It is applied for 5 days in acute arthritis caused by Mycoplasma in cattle less than 2 years old.
The product can be administered by slow intravenous or subcutaneous administration.
Acute mastitis caused by Escherichia coli: 5 mg enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, by slow intravenous
injection once daily for two consecutive days.
The second dose may be administered by the subcutaneous route. In this case, the withdrawal period following subcutaneous injection applies.
Not more than 10 ml should be administered at one injection site.
 
 
Sheep and goats
5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily by subcutaneous injection for 3 days. Not more than 6 ml should be administered at one injection site.
 
WITHDRAWAL PERIOD(S)
During the treatment and after the last drug administration, animals should not be sent to slaughter before 5 days for intravenous administration, 12 days for subcutaneous administration for cattle, 4 days for sheep and 6 days for goats. During the treatment and after the last drug administration, milk obtained from sheep for 3 days, from goats for 4 days, from cattle for 3 days in intravenous administration and 4 days in subcutaneous administration should not be offered for human consumption.
 
MARKETING PACKAGING
Sold as 20 ml, 50 ml 100 ml and 250 ml type II amber colored glass vials sealed with red bromobutyl rubber stopper and transparent aluminum flip-off cap in cardboard boxes.